Company intelligence / Profile preview

EUROAPI

Paris, Île-de-France, Franceeuroapi.com ↗

Ownership: Private
Employees: ~3400
Development stage: Other

Overview

EUROAPI operates as one of the world’s largest manufacturers of active pharmaceutical ingredients with over 200 APIs in its portfolio. It supplies both generic and complex/niche molecules using advanced chemistries and fermentation technologies. The company also provides contract development and manufacturing services to pharma clients globally. Its business includes both commercial supply of established APIs and custom development for new drugs through its CDMO division

Therapeutic areas: NeurologyInfectious DiseasesEndocrinologyOtherImmunologyCardiovascular
Modalities: Small moleculePeptidesOligonucleotidesBiologic
Industry: Contract Manufacturing Organization

Partnerships

Sanofi (major customer under long-term supply contracts)

Beyond the preview

Go deeper on EUROAPI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EUROAPI.

Explore the full profile